Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Methylated Biomarkers of Smoking as a Selection Tool in Participants for Lung Cancer Screening

NCT07631624 is registered in ClinicalTrials.gov with University Hospital, Antwerp as lead sponsor.

NCT NCT07631624
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07631624 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Methylated Biomarkers of Smoking as a Selection Tool in Participants for Lung Cancer Screening
Lead sponsor
University Hospital, Antwerp
Phase
Not applicable
Overall status
Recruiting
Start date
October 4, 2025
Completion date
January 1, 2028
Enrollment
1,000 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

dna methylation, epigenetics, lung cancer screening, risk stratification with biomarker, saliva